Oral systemic bioavailability of bisphenol A and bisphenol S in pigs

Environmental Health Perspectives

Volumn 127, Issue 7, 2019, Pages

  Gayrard, Véronique ^a,b   Lacroix, Marlène Z ^b   Grandin, Flore C ^a,b   Collet, Séverine H ^a,b   Mila, Hanna ^a,b   Viguié, Catherine ^a,b   Gély, Clémence A ^a,b   Rabozzi, Blandine ^a,b   Bouchard, Michèle ^c   Léandri, Roger ^d   Toutain, Pierre Louis ^b,e   Picard Hagen, Nicole ^a,b  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL GLUCURONIDE; BISPHENOL S; GLUCURONIDE; PHENOL DERIVATIVE; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; SULFONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG METABOLISM; ELIMINATION RATE CONSTANT; FEMALE; HORMONE ACTION; HUMAN; KIDNEY FUNCTION; LIMIT OF QUANTITATION; MAXIMUM CONCENTRATION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACOKINETIC PARAMETERS; PIG; PIGLET; PLASMA CLEARANCE; PRIORITY JOURNAL; RISK FACTOR; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VOLUME OF DISTRIBUTION; ANIMAL; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; POLLUTANT; TOXICOKINETICS;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ANIMALS; BENZHYDRYL COMPOUNDS; BIOLOGICAL AVAILABILITY; ENVIRONMENTAL POLLUTANTS; FEMALE; MALE; PHENOLS; SULFONES; SUS SCROFA; TOXICOKINETICS;

EID: 85070000291     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP4599     Document Type: Article

References (46)

1. Ahmed S, Atlas E. 2016. Bisphenol S-and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Int J Obes (Lond) 40(10):1566–1573, PMID: 27273607, https://doi.org/10.1038/ijo.2016.95.
2. Ahsan N, Ullah H, Ullah W, Jahan S. 2018. Comparative effects of Bisphenol S and Bisphenol A on the development of female reproductive system in rats; a neonatal exposure study. Chemosphere 197:336–343, PMID: 29407803, https://doi.org/10.1016/j.chemosphere.2017.12.118.
3. ANSES (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail). 2013. Opinion on the assessment of the risks associated with bisphenol A for human health, and on toxicological data and data on the use of bisphenols S, F, M, B, AP, AF and BADGE www.anses.fr/ en/content/opinion-assessment-risks-associated-bisphenol-human-health-and-toxicological-data-and-data [accessed 2 May 2018].
4. Boucher JG, Ahmed S, Atlas E. 2016. Bisphenol S induces adipogenesis in primary human preadipocytes from female donors. Endocrinology 157(4):1397–1407, PMID: 27003841, https://doi.org/10.1210/en.2015-1872.
5. Boucher JG, Boudreau A, Ahmed S, Atlas E. 2015. In vitro effects of Bisphenol A β-D-Glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes. Environ Health Perspect 123(12):1287–1293, PMID: 26018136, https://doi.org/10. 1289/ehp.1409143.
6. Boucher JG, Boudreau A, Atlas E. 2014. Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutr Diabetes 4:e102, PMID: 24418828, https://doi.org/10.1038/nutd.2013.43.
7. Boxenbaum H. 1980. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin. J Pharmacokinet Biopharm 8(2):165–176, PMID: 6107379, https://doi.org/10.1007/BF01065191.
8. Byon W, Fletcher CV, Brundage RC. 2008. Impact of censoring data below an arbitrary quantification limit on structural model misspecification. J Pharmacokinet Pharmacodyn 35(1):101–116, PMID: 17963024, https://doi.org/10.1007/s10928-007-9078-9.
9. Collet SH, Picard-Hagen N, Lacroix MZ, Puel S, Viguié C, Bousquet-Melou A, et al. 2015. Allometric scaling for predicting human clearance of bisphenol A. Toxicol Appl Pharmacol 284(3):323–329, PMID: 25759244, https://doi.org/10. 1016/j.taap.2015.02.024.
10. Conley JM, Hannas BR, Furr JR, Wilson VS, Gray LE. 2016. A demonstration of the uncertainty in predicting the estrogenic activity of individual chemicals and mixtures from an in vitro estrogen receptor transcriptional activation assay (T47D-KBluc) to the in vivo uterotrophic assay using oral exposure. Toxicol Sci 153(2):382–395, PMID: 27473340, https://doi.org/10.1093/toxsci/kfw134.
11. Danzl E, Sei K, Soda S, Ike M, Fujita M. 2009. Biodegradation of bisphenol A, bisphenol F and bisphenol S in seawater. Int J Environ Res Public Health 6(4):1472–1484, PMID: 19440529, https://doi.org/10.3390/ijerph6041472.
12. EFSA CEF Panel [EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF)]. 2015. Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA Journal 13(1):3978, https://doi.org/10.2903/j.efsa.2015.3978.
13. Eladak S, Grisin T, Moison D, Guerquin M-J, N'Tumba-Byn T, Pozzi-Gaudin S, et al. 2015. A new chapter in the bisphenol A story: Bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril 103(1):11–21, PMID: 25475787, https://doi.org/10.1016/j.fertnstert.2014.11.005.
14. FDA (Food and Drug Administration). 1999. Guidance for industry. Population Pharmacokinetics. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/population-pharmacokinetics [accessed 30 April 2019].
15. Gauderat G, Picard-Hagen N, Toutain P-L, Servien R, Viguié C, Puel S, et al. 2017. Prediction of human prenatal exposure to bisphenol A and bisphenol A glucuronide from an ovine semi-physiological toxicokinetic model. Sci Rep 7(1):15330, PMID: 29127374, https://doi.org/10.1038/s41598-017-15646-5.
16. Gayrard V, Gauderat G, Lacroix MZ, Viguié C, Bousquet-Melou A, Toutain P-L, et al. 2015. Comment on “In Vitro Effects of Bisphenol A β-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes.” Environ Health Perspect 123(12):A289, PMID: 26623714, https://doi.org/10.1289/ehp.1510315.
17. Goldinger DM, Demierre A-L, Zoller O, Rupp H, Reinhard H, Magnin R, et al. 2015. Endocrine activity of alternatives to BPA found in thermal paper in Switzerland. Regul Toxicol Pharmacol 71(3):453–462, PMID: 25579646, https://doi.org/10.1016/j.yrtph.2015.01.002.
18. Gramec Skledar D, Troberg J, Lavdas J, Peterlin Mašic L, Finel M. 2015. Differences in the glucuronidation of bisphenols F and S between two homolo-gous human UGT enzymes, 1A9 and 1A10. Xenobiotica 45(6):511–519, PMID: 25547628, https://doi.org/10.3109/00498254.2014.999140.
19. Grandin F, Picard-Hagen N, Gayrard V, Puel S, Viguié C, Toutain P-L, et al. 2017. Development of an on-line solid phase extraction ultra-high-performance liquid chromatography technique coupled to tandem mass spectrometry for quantification of bisphenol S and bisphenol S glucuronide: Applicability to toxi-cokinetic investigations. J Chromatogr A 1526:39–46, PMID: 29055528, https://doi.org/10.1016/j.chroma.2017.10.020.
20. Kararli TT. 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16(5):351–380, PMID: 8527686, https://doi.org/10.1002/bdd.2510160502.
21. Karrer C, Roiss T, von Goetz N, Gramec Skledar D, Peterlin Mašic L, Hungerbühler K. 2018. Physiologically based pharmacokinetic (PBPK) modeling of the bisphenols BPA, BPS, BPF, and BPAF with new experimental metabolic parameters: Comparing the pharmacokinetic behavior of BPA with its substitutes. Environ Health Perspect 126(7):077002, PMID: 29995627, https://doi.org/10.1289/EHP2739.
22. Kojima H, Takeuchi S, Sanoh S, Okuda K, Kitamura S, Uramaru N, et al. 2019. Profiling of bisphenol A and eight its analogues on transcriptional activity via human nuclear receptors. Toxicology 413:48–55, PMID: 30582956, https://doi.org/10.1016/j.tox.2018.12.001.
23. Kuruto-Niwa R, Nozawa R, Miyakoshi T, Shiozawa T, Terao Y. 2005. Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ Toxicol Pharmacol 19(1):121–130, PMID: 21783468, https://doi.org/10.1016/j.etap.2004.05.009.
24. Lacroix MZ, Puel S, Collet SH, Corbel T, Picard-Hagen N, Toutain PL, et al. 2011. Simultaneous quantification of bisphenol A and its glucuronide metabolite (BPA-G) in plasma and urine: Applicability to toxicokinetic investigations. Talanta 85(4):2053–2059, PMID: 21872057, https://doi.org/10.1016/j.talanta.2011. 07.040.
25. Le Fol V, Aït-Aïssa S, Cabaton N, Dolo L, Grimaldi M, Balaguer P, et al. 2015. Cell-specific biotransformation of benzophenone-2 and bisphenol-s in zebrafish and human in vitro models used for toxicity and estrogenicity screening. Environ Sci Technol 49(6):3860–3868, PMID: 25679259, https://doi.org/10.1021/es505302c.
26. Lehmler H-J, Liu B, Gadogbe M, Bao W. 2018. Exposure to bisphenol A, bisphenol F, and bisphenol S in U.S. adults and children: The National Health and Nutrition Examination Survey 2013-2014. ACS Omega 3(6):6523–6532, PMID: 29978145, https://doi.org/10.1021/acsomega.8b00824.
27. Li M, Gehring R, Lin Z, Riviere J. 2015. A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling. J Pharm Sci 104(4):1230–1239, PMID: 25641543, https://doi.org/10.1002/jps.24341.
28. Liao C, Kannan K. 2014. A survey of bisphenol A and other bisphenol analogues in foodstuffs from nine cities in China. Food Additives & Contaminants: Part A 31(2):319–329, PMID: 24262000, https://doi.org/10.1080/19440049.2013.868611.
29. Matthews JB, Twomey K, Zacharewski TR. 2001. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol 14(2):149–157, PMID: 11258963, https://doi.org/10.1021/tx0001833.
30. Molina-Molina JM, Amaya E, Grimaldi M, Sáenz J-M, Real M, Fernández MF, et al. 2013. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol Appl Pharmacol 272(1):127–136, PMID: 23714657, https://doi.org/10. 1016/j.taap.2013.05.015.
31. Oh J, Choi JW, Ahn Y-A, Kim S. 2018. Pharmacokinetics of bisphenol S in humans after single oral administration. Environ Int 112:127–133, PMID: 29272776, https://doi.org/10.1016/j.envint.2017.11.020.
32. Philips EM, Jaddoe VWV, Asimakopoulos AG, Kannan K, Steegers EAP, Santos S, et al. 2018. Bisphenol and phthalate concentrations and its determinants among pregnant women in a population-based cohort in the Netherlands, 2004-5. Environ Res 161:562–572, PMID: 29245124, https://doi.org/10.1016/j. envres.2017.11.051.
33. Rochester JR, Bolden AL. 2015. Bisphenol S and F: A systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect 123(7):643–650, PMID: 25775505, https://doi.org/10.1289/ehp.1408989.
34. Rosenmai AK, Dybdahl M, Pedersen M, Alice van Vugt-Lussenburg BM, Wedebye EB, Taxvig C, et al. 2014. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci 139(1):35–47, PMID: 24563381, https://doi.org/10.1093/toxsci/kfu030.
35. Skledar DG, Schmidt J, Fic A, Klopcic I, Trontelj J, Dolenc MS, et al. 2016. Influence of metabolism on endocrine activities of bisphenol S. Chemosphere 157:152–159, PMID: 27213244, https://doi.org/10.1016/j.chemosphere.2016.05.027.
36. Teeguarden J, Hanson-Drury S, Fisher JW, Doerge DR. 2013. Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population? Food Chem Toxicol 62:949–963, PMID: 23959105, https://doi.org/10.1016/j.fct.2013.08.001.
37. Thayer KA, Doerge DR, Hunt D, Schurman SH, Twaddle NC, Churchwell MI, et al. 2015. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int 83:107–115, PMID: 26115537, https://doi.org/10.1016/j.envint.2015.06.008.
38. Tucker DK, Hayes Bouknight S, Brar SS, Kissling GE, Fenton SE. 2018. Evaluation of prenatal exposure to bisphenol analogues on development and long-term health of the mammary gland in female mice. Environ Health Perspect 126(8):087003, PMID: 30102602, https://doi.org/10.1289/EHP3189.
39. Ullah A, Pirzada M, Jahan S, Ullah H, Shaheen G, Rehman H, et al. 2018. Bisphenol A and its analogs bisphenol B, bisphenol F, and bisphenol S: Comparative in vitro and in vivo studies on the sperms and testicular tissues of rats. Chemosphere 209:508–516, PMID: 29940534, https://doi.org/10.1016/j.chemosphere.2018.06.089.
40. Varma MVS, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, et al. 2010. Physicochemical space for optimum oral bioavailability: Contribution of human intestinal absorption and first-pass elimination. J Med Chem 53(3):1098–1108, PMID: 20070106, https://doi.org/10.1021/jm901371v.
41. Viñas R, Goldblum RM, Watson CS. 2013. Rapid estrogenic signaling activities of the modified (chlorinated, sulfonated, and glucuronidated) endocrine disruptor bisphenol A. Endocrine Disruptors 1(1):e25411, https://doi.org/10.4161/endo. 25411.
42. Viñas R, Watson CS. 2013. Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells. Environ Health 12:26, PMID: 23530988, https://doi.org/10.1186/1476-069X-12-26.
43. Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W. 2002. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 15(10):1281–1287, PMID: 12387626, https://doi.org/10.1021/tx025548t.
44. Wu LH, Zhang XM, Wang F, Gao CJ, Chen D, Palumbo JR, et al. 2018. Occurrence of bisphenol S in the environment and implications for human exposure: A short review. Sci Total Environ 615:87–98, PMID: 28963899, https://doi.org/10. 1016/j.scitotenv.2017.09.194.
45. Ye X, Wong L-Y, Kramer J, Zhou X, Jia T, Calafat AM. 2015. Urinary concentrations of bisphenol A and three other bisphenols in convenience samples of U.S. adults during 2000-2014. Environ Sci Technol 49(19):11834–11839, PMID: 26360019, https://doi.org/10.1021/acs.est.5b02135.
46. Zhou X, Kramer JP, Calafat AM, Ye X. 2014. Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J Chromatogr B Analyt Technol Biomed Life Sci 944:152–156, PMID: 24316527, https://doi.org/10.1016/j.jchromb.2013.11.009.